On July 28, 2015, we entered into a subscription agreement for ordinary shares, or the Subscription Agreement, with Invesco Perpetual High Income Fund, Woodford Patient Capital Trust plc and LF
Woodford Equity Income Fund, or, collectively, the Existing Investors, and Novartis.